Qynapse

Qynapse develops AI-powered neuroimaging software for central nervous system disorders. Its QyScore® platform processes MRI scans to label, visualize, and quantify brain structures and lesions, producing measurements that can support clinical assessment and monitoring. Qynapse also describes QyPredict® as a research-use-only product in development for combining neuroimaging with other health and research measures. The company serves clinical, pharmaceutical research, and healthcare stakeholders.